Literature DB >> 11053225

Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate.

W H Kaesemeyer1, A A Ogonowski, L Jin, R B Caldwell, R W Caldwell.   

Abstract

Tolerance to glyceryl trinitrate (GTN) involves superoxide (O(2)(*-)) production by endothelial cells. Nitric oxide synthase (NOS) produces O(2)(*-) when L-arginine (L-arg) is limited. The purpose of this study was to test the hypothesis that GTN stimulates NOS to increase O(2)(*-) synthesis in endothelial cells when L-arg is limited. Production of O(2)(*-) by bovine aortic endothelial cells (BAEC, passages 3 - 5) was determined by spectrophotometrically measuring superoxide dismutase-inhibited reduction of ferricytochrome C to ferrocytochrome C. Cells were incubated in buffer without L-arg. O(2)(*-) production was measured using BAEC either untreated or treated with L-NAME or L-arg alone or following treatment with GTN (10(-9) to 10(-6) M) for 30 min or DPTA NONOate (10(-7) and 10(-6) M) alone or with GTN or DPTA NONOate after pretreatment with nitro-L-arginine methyl ester (L-NAME), L-arg or their inactive enantiomers, D-NAME or D-arg (all 5 x 10(-4) M) (n=6 - 7/group). L-NAME alone produced a 69% reduction in O(2)(*-) levels. Treatment with L-arg alone had no effect. Cells treated with GTN alone exhibited an increase in O(2)(*-). This effect was prevented by pretreatment with either L-NAME or L-arg, and was unaffected by D-NAME or D-arg. We observed a dose-response relationship in O(2)(*-) production to GTN over a range of 10(-9) to 10(-7) M. The NO donor, DPTA-NONOate, unlike GTN, did not have a significant effect on O(2)(*-) production. In conclusion, endothelial NOS is a site of O(2)(*-) synthesis in endothelial cells activated by GTN.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053225      PMCID: PMC1572421          DOI: 10.1038/sj.bjp.0703665

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  The angiotensin II-receptor antagonist losartan does not prevent hemodynamic or vascular tolerance to nitroglycerin.

Authors:  S D Milone; E R Azevedo; C Forster; J D Parker
Journal:  J Cardiovasc Pharmacol       Date:  1999-11       Impact factor: 3.105

2.  Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects.

Authors:  C M Maragos; D Morley; D A Wink; T M Dunams; J E Saavedra; A Hoffman; A A Bove; L Isaac; J A Hrabie; L K Keefer
Journal:  J Med Chem       Date:  1991-11       Impact factor: 7.446

3.  Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production.

Authors:  A A Ogonowski; W H Kaesemeyer; L Jin; V Ganapathy; F H Leibach; R W Caldwell
Journal:  Am J Physiol Cell Physiol       Date:  2000-01       Impact factor: 4.249

4.  Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin.

Authors:  G Abou-Mohamed; W H Kaesemeyer; R B Caldwell; R W Caldwell
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 5.  Cell and tissue responses to oxidative damage.

Authors:  Y M Janssen; B Van Houten; P J Borm; B T Mossman
Journal:  Lab Invest       Date:  1993-09       Impact factor: 5.662

6.  Intracellular redox state determines whether nitric oxide is toxic or protective to rat oligodendrocytes in culture.

Authors:  P A Rosenberg; Y Li; S Ali; N Altiok; S A Back; J J Volpe
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

7.  Bradykinin induces superoxide anion release from human endothelial cells.

Authors:  J A Holland; K A Pritchard; M A Pappolla; M S Wolin; N J Rogers; M B Stemerman
Journal:  J Cell Physiol       Date:  1990-04       Impact factor: 6.384

8.  Superoxide anion is an endothelium-derived contracting factor.

Authors:  Z S Katusic; P M Vanhoutte
Journal:  Am J Physiol       Date:  1989-07

9.  The reaction of no with superoxide.

Authors:  R E Huie; S Padmaja
Journal:  Free Radic Res Commun       Date:  1993

10.  On the mechanism of NO release from sydnonimines.

Authors:  M Feelisch; J Ostrowski; E Noack
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

View more
  21 in total

Review 1.  Endothelium-derived free radicals: for worse and for better.

Authors:  P M Vanhoutte
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Arginase II inhibition prevents nitrate tolerance.

Authors:  S M L Khong; K L Andrews; N N Huynh; K Venardos; A Aprico; D L Michell; M Zarei; K T Moe; G J Dusting; D M Kaye; J P F Chin-Dusting
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 3.  The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors:  Yagna P R Jarajapu; Maria B Grant
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

4.  Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation.

Authors:  Azza B El-Remessy; Huda E Tawfik; Suraporn Matragoon; Bindu Pillai; Ruth B Caldwell; R William Caldwell
Journal:  Exp Diabetes Res       Date:  2010-11-01

5.  Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.

Authors:  Amal Hofni; Basim A Shehata Messiha; Safwat A Mangoura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-11       Impact factor: 3.000

Review 6.  The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles.

Authors:  B Mayer; M Beretta
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

7.  Melatonin inhibits nitrate tolerance in isolated coronary arteries.

Authors:  Stephen T O'Rourke; Hana Hammad; Philippe Delagrange; Elizabeth Scalbert; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

8.  Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor.

Authors:  Azza B El-Remessy; M Ali Behzadian; Gamal Abou-Mohamed; Telina Franklin; Robert W Caldwell; Ruth B Caldwell
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  Diabetes-induced coronary vascular dysfunction involves increased arginase activity.

Authors:  Maritza J Romero; Daniel H Platt; Huda E Tawfik; Mohamed Labazi; Azza B El-Remessy; Manuela Bartoli; Ruth B Caldwell; Robert W Caldwell
Journal:  Circ Res       Date:  2007-10-25       Impact factor: 17.367

10.  Role of the general base Glu-268 in nitroglycerin bioactivation and superoxide formation by aldehyde dehydrogenase-2.

Authors:  M Verena Wenzl; Matteo Beretta; Antonius C F Gorren; Andreas Zeller; Pravas K Baral; Karl Gruber; Michael Russwurm; Doris Koesling; Kurt Schmidt; Bernd Mayer
Journal:  J Biol Chem       Date:  2009-06-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.